Topics: Hypoalbuminemia, GLOMERULONEPHRITIS, URINARY TRACT INFECTION, ACTUE KIDNEY INJURY, CHRONIC RENAL FAILURE, END-STAGE RENAL DISEASE, RENAL REPLACEMENT THERAPY, Potter’s syndrome, Unilateral agenesis, aplasia, Hypoplasia, Multicystic kidney, Medullary sponge Kidney, Solitary cyst, Horse-shoe kidney, Ectopic kidney, Hydramnious, Pelvic Hydronephrosis, Ureterocele, RENAL BIOPSY, HYPERTENSION, ENURESIS

Topics: Sickle Mutation, HAPLOTYPE DISTRIBUTION, KUWAITI BETA S CHROMOSOMES, HAND AND FOOT SYNDROME, Painful vaso-occlusive crisis, Visceral sequestration crises, Aplastic crises, Bone marrow transplantation, Allogeneic bone marrow transplantation, Gene therapy, Hydroxyurea, Sickling test, Priapism

Topics: antibiotic, antimicrobial drugs, Chemotherapeutic drug resistance, Antimicrobial drug Selection, Antimicrobial drug Selection, Antimicrobial drug treatment, Antimicrobial Therapy

Topics: PLANT-DRUG DISCOVERY, Drug Discovery Process, Genomics, proteomics, Current therapy, Assay Development, Hit Validation, Lead Compound, Lead Optimisation, Preclinical Evaluation, Preclinical toxicity studies, In vivo tests, Test validity, Multiple Ascending Dose, drug Development

Topics: antimicrobial drugs, antimicrobial therapy, gram-positive, gram-negative

Topics: CISPLATIN, CARBOPLATIN, OXALIPLATIN, Aromatase Inhibitors, Breast Cancer, Hormone Therapy, Anastrozole, Letrozole, Exemestane

Topics: Normal Blood Pressure Regulation, Hydraulic equation, Baroreceptors effect, Antihypertensive therapy, Diuretics, Sympatholytics drugs, Calcium channel blocker, Angiotensin converting enzyme inhibitors, Angiotensin converting enzyme inhibitors, Angotensin 11 receptor antagonists, Vasodilators, SYMPATHOLYTIC AGENTS, Cardioselective β-blockers, α1-adrenoceptor blockers, Centrally-acting sympatholytics, Adrenergic neurone blockers

Topics: insulin therapy, diabetic ketoacidosis, diabetic coma, hypoglycemia

Topics: ATHEROGENESIS, Endothelial dysfunction, Smooth muscle cell dysfunction, Architectural disruption, LIPOPROTEIN PARTICLES, Primary chylomicronemia, Primary hypertriglyceridemias, Familial hypertriglyceridemia, Familial combined hyperlipoproteinemia, familial dysbetalipoproteinemia, Primary hypercholesterolemias, Familial hypercholesterolemia, Familial ligand-defective Apolipoprotein B, Familial combined hyperlipoproteinemia, hyperlipoproteinemia, Hypercholesterolemias, Hypertriglyceridemias, REDUCTASE INHIBITORS, STATINS, FIBRATES, Fibric acid derivatives, BILE ACID-BINDING RESINS, NICOTINIC ACID, NIACIN, INTESTINAL STEROL ABSORPTION, EZETIMIBE, COMBINATION THERAPY

Topics: Fibrinolytic system, Streptokinase, Anistreplase, Anisoylated plasminogen-streptokinase activator complex, Urokinase, Alteplase, recombinant tissue Plasminogen Activator, Reteplase, recombinant tissue plasminogen activators, Tenecteplase, thrombolytic therapy, Antiplasmin, Antifibrinolytics, Aminocaproic Acid, tranexamic acid, Antiplatelet drugs, platelet aggregation, platelet inhibition, Aspirin, Dipyridamole, Ticlodipine, clopidogrel, Abciximab